Literature DB >> 29580767

Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study.

Arrigo F G Cicero1, Stefano Gitto2, Federica Fogacci3, Martina Rosticci3, Marina Giovannini3, Sergio D'Addato3, Pietro Andreone2, Claudio Borghi3.   

Abstract

BACKGROUND: Non-Alcoholic Fatty Liver Disease (NAFLD) is associated to increased risk of cardiovascular disease. Our aim was to evaluate association of indexes of fatty liver with arterial stiffness (AS).
METHODS: We analyzed data of adult volunteers visited during the last Brisighella survey. We evaluated the Pulse Wave Velocity (PWV) and the following non-invasive indexes of liver steatosis: Fatty Liver Index (FLI), Lipid Accumulation Product (LAP), Hepatic Steatosis Index (HSI). We compared patients according to the risk of Non-Alcoholic Steatohepatitis (NASH): low-risk (BMI < 28 and no diabetes), intermediate-risk (BMI ≥ 28 or diabetes), high-risk (BMI ≥ 28 and diabetes). Multiple Linear Regression analysis was assessed for predictors of AS.
RESULTS: We studied 1731 volunteers. In subjects with low metabolic risk, HSI (RR = 0.138, 95%CI 0.105-0.170, p < 0.001), FLI (RR = 0.024, 95%CI 0.016-0.032, p < 0.001), LAP (RR = 0.014, 95%CI 0.008-0.020, p < 0.001) and Serum Uric Acid (RR = 0.150, 95%CI 0.024-0.275, p = 0.019) were significant predictors of AS. HSI and FLI emerged as predictors of PWV in intermediate risk group (RR = 0.116, 95%CI 0.071-0.160, p < 0.001; RR = 0.010, 95%CI 0.001-0.020, p = 0.041). In volunteers with high risk, FLI and Uric Acid were related to PWV (RR = 0.049, 95%CI 0.011-0.087, p = 0.013; RR = 0.632, 95% CI 0.222-1.041, p = 0.003).
CONCLUSION: Fatty liver indirect indexes were associated to AS in subjects with different metabolic risk profiles.
Copyright © 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arterial stiffness; Liver steatosis; NAFLD; NASH; Population study

Mesh:

Substances:

Year:  2018        PMID: 29580767     DOI: 10.1016/j.ejim.2018.03.010

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  15 in total

1.  Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study.

Authors:  Federica Fogacci; Elisabetta Rizzoli; Marina Giovannini; Marilisa Bove; Sergio D'Addato; Claudio Borghi; Arrigo F G Cicero
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

2.  Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial.

Authors:  Arrigo F G Cicero; Federica Fogacci; Marilisa Bove; Marina Giovannini; Claudio Borghi
Journal:  Eur J Nutr       Date:  2020-05-16       Impact factor: 5.614

3.  The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study.

Authors:  Stefanos Tyrovolas; Demosthenes B Panagiotakos; Ekavi N Georgousopoulou; Christina Chrysohoou; John Skoumas; William Pan; Dimitrios Tousoulis; Christos Pitsavos
Journal:  Therap Adv Gastroenterol       Date:  2019-06-23       Impact factor: 4.409

4.  Relationship Between the Lipid Accumulation Product Index and Arterial Stiffness in the Chinese Population With Hypertension: A Report From the China H-Type Hypertension Registry Study.

Authors:  Yumeng Shi; Lihua Hu; Minghui Li; Wei Zhou; Tao Wang; Lingjuan Zhu; Huihui Bao; Ping Li; Xiaoshu Cheng
Journal:  Front Cardiovasc Med       Date:  2022-01-21

5.  Correlation of the Fatty Liver Index with the Pathophysiological Abnormalities Associated with Cardiovascular Risk Markers in Japanese Men without any History of Cardiovascular Disease: Comparison with the Fibrosis-4 Score.

Authors:  Yoichi Iwasaki; Kazuki Shiina; Chisa Matsumoto; Hiroki Nakano; Masatsune Fujii; Akira Yamashina; Taishiro Chikamori; Hirofumi Tomiyama
Journal:  J Atheroscler Thromb       Date:  2020-07-23       Impact factor: 4.928

6.  Atherogenic Index of Plasma (AIP) a Tool to Assess Changes in Cardiovascular Disease Risk Post Laparoscopic Sleeve Gastrectomy.

Authors:  Eman Al Shawaf; Ebaa Al-Ozairi; Fahad Al-Asfar; Anwar Mohammad; Shaima Al-Beloushi; Sriraman Devarajan; Fahd Al-Mulla; Jehad Abubaker; Hossein Arefanian
Journal:  J Diabetes Res       Date:  2020-08-01       Impact factor: 4.011

7.  Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver.

Authors:  Thomas Jensen; Koichiro Niwa; Ichiro Hisatome; Mehmet Kanbay; Ana Andres-Hernando; Carlos A Roncal-Jimenez; Yuka Sato; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson; Masanari Kuwabara
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

8.  Interaction of lipid accumulation product and family history of hypertension on hypertension risk: a cross-sectional study in the Southern Chinese population.

Authors:  JunXuan Huang; XinYu Bao; YiXian Xie; XiaoXia Zhang; Xin Peng; Yan Liu; MengJiao Cheng; JinXiang Ma; PeiXi Wang
Journal:  BMJ Open       Date:  2019-11-28       Impact factor: 2.692

9.  Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Federica Fogacci; Elisabetta Rizzoli; Sergio D'Addato; Claudio Borghi
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

10.  Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Federica Fogacci; Giuseppe Derosa; Angela D'Angelo; Fulvio Ventura; Elisabetta Rizzoli; Sergio D'Addato; Claudio Borghi
Journal:  Biomedicines       Date:  2022-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.